AN-788
AN-788, also known as NSD-788, is an experimental medication which was originated by NeuroSearch and is under development by Aniona and Saniona for the treatment of major depressive disorder. It was also under development for anxiety disorders, but development for this indication was discontinued. The drug acts as a serotonin–dopamine reuptake inhibitor (SDRI). As of April 2016, it is in phase I clinical trials for major depressive disorder.
Link from a Wikipage to another Wikipage
primaryTopic
AN-788
AN-788, also known as NSD-788, is an experimental medication which was originated by NeuroSearch and is under development by Aniona and Saniona for the treatment of major depressive disorder. It was also under development for anxiety disorders, but development for this indication was discontinued. The drug acts as a serotonin–dopamine reuptake inhibitor (SDRI). As of April 2016, it is in phase I clinical trials for major depressive disorder.
has abstract
AN-788, also known as NSD-788, ...... for major depressive disorder.
@en
CAS number
1618658-43-7
Wikipage page ID
56,550,493
page length (characters) of wiki page
Wikipage revision ID
994,844,976
Link from a Wikipage to another Wikipage
CAS number
synonyms
NSD-788
@en
wikiPageUsesTemplate
subject
comment
AN-788, also known as NSD-788, ...... for major depressive disorder.
@en
label
AN-788
@en